In the depths of time, when the universe was but a tender babe, an epoch unfathomable, there existed naught but primordial cells.
1.5 billion years ago, a singular ancient invasion by a eubacteria of an archea host occurred.
This invasion or engulfing, depending on who or what we give the moral high-ground, may have been the quintessential step in the most important evolutionary leap since the origin of life itself:
The transition from a primitive cell to a complex higher organism (eukaryote).
According to an old story, a lord of ancient China once asked his physician, a member of a family of healers, which of them was the most skilled in the art.
The physician, whose reputation was such that his name became synonymous with medical science in China, replied, “My eldest brother sees the spirit of sickness and removes it before it takes shape, so his name does not get out of the house.
“My elder brother cures sickness when it is still extremely minute, so his name does not get out of the neighbourhood. “As for me, I puncture veins, prescribe potions, and massage skin, so from time to time my name gets out and is heard among the lords.”
Statins act by reversibly and competitively inhibiting HMG-CoA reductase, a key enzyme in the mevalonate pathway of which cholesterol is a final product.
Cholesterol acts as an intermediate for steroid hormones, bile acids and vitamin D, CoQ10 and is crucial to the integrity of all cell membranes.
This partly explains the plethora of statin-associated symptoms (SAS) that manifest in up to 30% of patients.